Journal of Virology, February 1999, p. 1227-1234, Vol. 73, No. 2
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.

Departments of Entomology and Genetics, University of Georgia, Athens, Georgia 30602,1 and Department of Biological Sciences, Columbia University, New York, New York 100272
Received 10 August 1998/Accepted 29 October 1998
| |
ABSTRACT |
|---|
|
|
|---|
In vertebrates, p53 participates in numerous biological processes including cell cycle regulation, apoptosis, differentiation, and oncogenic transformation. When insect SF-21 cells were infected with a recombinant of the baculovirus Autographa californica nuclear polyhedrosis virus (AcMNPV) overexpressing human p53, p53 formed a stable complex with the product of the AcMNPV orf92, a novel protein p33. The interaction between p53 and p33 was further confirmed by immunoprecipitation studies. When individually expressed in SF-21 cells, human p53 localized mainly in the nucleus whereas baculovirus p33 displayed diffuse cytoplasmic staining and punctuate nuclear staining. However, coexpression of p33 with p53 resulted in exclusive nuclear localization of p33. In both SF-21 and TN-368 cells, p53 expression induced typical features of apoptosis including nuclear condensation and fragmentation, oligonucleosomal ladder formation, cell surface blebbing, and apoptotic body formation. Coexpression of p53 with a baculovirus inhibitor of apoptosis, p35, OpIAP, or CpIAP, blocked apoptosis, whereas coexpression with p33 enhanced p53-mediated apoptosis approximately twofold. Expression of p53 in SF-21 cells stably expressing OpIAP inhibited cell growth in the presence or absence of p33. Thus, human p53 can influence both insect cell growth and death and baculovirus p33 can modulate the death-inducing effects of p53.
| |
INTRODUCTION |
|---|
|
|
|---|
The p53 gene, a tumor suppressor gene which is mutated in more than 50% of human cancers, encodes a multifunctional protein which plays a pivotal role in the regulation of cell cycle progression and programmed cell death (reviewed in references 2, 17, 18, 25, 26, 30, 31, and 58). A number of factors affect the decision of cells to undergo cell cycle arrest or apoptosis. p53-mediated apoptosis prevails under conditions in which DNA is damaged, survival factors are limiting, or an activated oncogene forces the cell into a replicative cycle. Regulation by p53 may be exerted by direct protein signaling and/or by its ability to transcriptionally activate other genes.
p53, a sequence-specific transcriptional activator (reviewed in
reference 53), has been shown to activate under
physiological conditions a number of cellular genes which mediate its
roles in cell cycle arrest and apoptosis. p21 is likely to be its main effector in inducing a G1 block (reviewed in reference
26), while a more recently identified target,
14-3-3
, has been proposed to be responsible, at least in part, for
its G2 arrest (22). The ability of p53 to induce
apoptosis is more complex because in some cases the transactivation
function of p53 has been shown to be required, while in others, a
transactivation-independent function was demonstrated (reviewed in
reference 26). p53 target genes which play roles in
apoptosis include bax and IGF-BP3 (reviewed in
references 17 and 26).
Additionally, it was recently shown that a class of genes termed PIG
genes, some of which function in reactive oxygen species metabolism,
are specifically induced by p53 during the apoptotic process
(43). In keeping with its function as a transcriptional
activator, p53 has been shown to interact with several polypeptide
components of the general transcription factors TFIID and TFIIH
(17, 26) and also with the p300/CBP coactivators (3,
19, 32). There is evidence that p53 may interact with and
regulate DNA repair and/or replication factors as well (26).
The transcription-independent role of p53 in apoptosis is not fully understood, but protein interactions with p53 may be involved. Perhaps the best-studied p53 interactor is the oncoprotein MDM2, which binds to the N terminus of p53 (9, 28, 39, 40, 42). MDM2 both inhibits the ability of p53 to activate transcription (39, 40, 51) and targets p53 for proteasome-mediated degradation (7, 21, 27). Some additional proteins which may functionally interact with p53 include the c-Abl nuclear tyrosine kinase (16), the Wilms' tumor suppressor protein Wt1 (35), and the p33ING1 tumor suppressor (15).
Many DNA viruses encode p53 binding proteins that affect p53 function. The simian virus 40 large tumor antigen binds to the p53 central conserved region and represses its transactivation function (5, 13). The adenovirus 55-kDa protein E1B binds to the p53 activation domain in a region which overlaps the MDM2 interaction region (33) and causes p53 to repress transcription (60), while the adenovirus E4orf6 product interacts with p53 and abrogates TATA binding protein-associated factor binding (12). The interaction of the human papillomavirus E6 product with p53 leads to ubiquitin-mediated degradation of the p53 protein (24). It has also been reported that the hepatis B virus X protein (57) as well as Epstein-Barr virus-encoded EBNA-5 (49) and BZLF1 (61) can bind to p53. The fact that a number of viruses encode gene products that can interact with p53 suggests that alteration of p53 apoptotic function is a prerequisite for mounting a productive viral infection (reviewed in references 50 and 58).
Baculoviruses have two classes of genes which can block apoptosis induced during viral infection: p35-like genes and inhibitor of apoptosis (IAP) genes (reviewed in reference 11). p35 of Autographa californica nuclear polyhedrosis virus (AcMNPV) is a general, stoichiometric inhibitor of caspases, a family of cysteine proteases which are activated by proteolytic processing and are involved in the execution of cell death. AcMNPV infection of Spodoptera frugiperda SF-21 cells activates SF-caspase-1 (1, 37, 47). Whereas p35 blocks the activity of mature SF-caspase-1, some members of the IAP family (e.g., baculovirus OpIAP) block the processing and activation of this caspase (47). The mechanism by which baculoviruses activate caspases remains unclear, but it is known that baculovirus DNA replication and/or late viral gene expression are required for maximum levels of apoptosis (10, 29). Overexpression of ie-1, a baculovirus gene involved in both viral DNA replication and gene expression, is sufficient to induce apoptosis in SF-21 cells (44), but other factors are also likely to be involved.
In the present study, we have found that AcMNPV encodes a 33-kDa protein which interacts with the human p53 protein. This observation led us to investigate the activity of human p53 in insect cells and how p33 binding influences p53 activity. We provide evidence that p53 expression induces either cell growth arrest or apoptosis, depending on the presence of a member of the IAP family of apoptosis inhibitors in insect cells, and that baculovirus p33 enhances p53-mediated apoptosis in insect cells.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Cells and media. S. frugiperda IPLB-SF21 (SF-21) (52), hsOpIAPpacR (38), and Trichoplusia ni TN-368 (23) cells were maintained at 27°C in TC-100 growth medium (GIBCO BRL, Gaithersburg, Md.) supplemented with 10% fetal bovine serum and 0.26% tryptose broth (Difco Laboratories, Inc., Detroit, Mich.) as described previously (41).
Plasmids. phsEHp53 was constructed by replacing the ced9 open reading frame (ORF) within the BglII-EcoRI fragment of phsEpihisced-9VI+ (48) with a BglII-SmaI fragment containing the human p53 ORF. The human p53 insert was prepared by PCR using pEV55Hp53 as a template, a 5' primer in the sense orientation (5'-CGAGATCTGAGGAGCCGCAGTCAGATC), and a 3' primer in the antisense orientation (5'-TCCCCCGGGTCAGTCTGAGTCAGGCC). The PCR product was digested with BglII and SmaI before ligation. phsORF92F was constructed by inserting a BglII-SmaI-digested PCR product, containing the baculovirus orf92 (4), in place of the cat ORF within the BglII-EcoRI fragment of pHSP70PLVI+CAT (10). The primers used for PCR were 5'-GCGAGATCTATGATACCGCTGACGC (corresponding to the 5' orf92 end) and 5'-TCCCCCGGGTTATTTGTCATCGTCGTCCTTGTAGTCTTGCAAATTTAAC (corresponding to the 3' end of orf92), extended with the sequence DYKDDDDK, constituting a Flag tag. pXE2213 was used as the template and was constructed by cloning the 2,213-bp XhoI-EcoRI fragment containing the AcMNPV orf92 (4) into pBluescript II KS+ (Stratagene, La Jolla, Calif.). Plasmid phsFlagHisVI+ was constructed to facilitate the N-terminal tagging of proteins with a Flag epitope and a nickel binding site (His6 tag). to construct phsFlagHisVI+, Op-iap, the gene encoding OpIAP, was removed from a plasmid expressing Flag-Op-iap (54) and replaced with overlapping oligonucleotides coding for a His6 tag and containing sites of restriction endonucleases BglII, Bsu36I, XmaI, and NotI. The sequence of plasmid phsFlagHisVI+ in the Flag-His6 tag region was 1ATGAGCTCCCGAGACTACAAGGACGACGATGACAAACTCGATCGAGATTCCCGGCATCATCATCATCATCACAGATCTCCTGAGGCCCGGGCGGCCGC98, where the translation initiation codon is from nucleotides (nt) 1 to 3, followed by a Flag tag (nt 13 to 36), a His6 tag (nt 54 to 72), and a polylinker (nt 73 to 98). To construct phsFHORF92, PCR-amplified orf92 was digested with BglII and SmaI and inserted between the BglII and SmaI sites of phsFlagHisVI+. The 5' primer for orf92 amplification was same as that used to construct phsORF92F; the 3' primer was 5'-TCCCCCGGGTTATTGCAAATTTAAC. Plasmids expressing cat (pHSP70PLVI+CAT), p35 (pHSP35VI+), Op-iap (pHSOpIAPVI+), Cp-iap (pHSCpIAPVI+), Ac-iap (pHSAcIAPVI+), N-terminally hemagglutinin (HA).11His6-tagged cat (pHSP70VI+EpihisCAT) or Op-iap (pHSP70VI+EpihisOpIAP), and C-terminally Flag-tagged rpr (pHSP70VI+RPR-Flag) were previously described (10, 20, 54).
Coimmunoprecipitations and immunoblotting. SF-21 cells (106) in 60-mm-diameter culture dishes were transiently transfected by using Lipofectin (41) and 4 µg of each plasmid expressing Flag- or HA.11 epitope (Epi)-tagged genes under Drosophila melanogaster hsp70 promoter (Phsp70) control. At 16 h after transfection, cells were mock or AcMNPV infected at a multiplicity of infection of 5 and heat shocked 6 h following infection for 30 min at 42°C as described previously (10). At 3 h after heat shock, cells were harvested, pelleted at 2,000 × g for 3 min, and lysed in 200 µl of 50 mM Tris-HCl (pH 8.0)-50 mM NaCl-0.5% Nonidet P-40 (NP-40)-1 mM dithiothreitol-1 mM phenylmethylsulfonyl fluoride (NP-40 lysis buffer). The lysate was centrifuged at 2,000 × g for 5 min, and 20 µl of the supernatant was reserved for Western blotting as a positive control of expression. Ten microliters of anti-Flag M2 affinity resin (Eastman Kodak Co., New Haven, Conn.) was incubated with the remainder of the supernatant for 3 h at 4°C with vigorous agitation. The resin was washed five times in 1 ml of NP-40 lysis buffer, and bound proteins were eluted with 0.1 M glycine-HCl (pH 3.5) as recommended by manufacturer. The lysate and eluted samples were subjected to electrophoresis through sodium dodecyl sulfate (SDS)-10% polyacrylamide gels, and proteins were transferred onto Hybond ECL enhanced chemiluminescence membranes (Amersham, Buckinghamshire, United Kingdom). Epi-tagged proteins were detected with mouse HA.11 (anti-Epi) monoclonal antibody and rabbit anti-mouse immunoglobulin G (IgG)-horseradish peroxidase conjugate (Amersham). Flag-tagged proteins were detected with mouse anti-Flag monoclonal antibody M2 (Eastman Kodak) and rabbit anti-mouse IgG-horseradish peroxidase conjugate. Immunoblots were visualized with the ECL Western blotting system.
Immunofluorescence. SF-21 cells (0.5 × 106) were seeded on glass coverslips in 35-mm-diameter culture dishes and transfected with 1 µg of each plasmid expressing Flag- or Epi-tagged genes under Phsp70 control. Transfected cells were infected and then heat shocked as described above. At 3 h after heat shock, cells were fixed and treated as previously described (45). Flag- or Epi-tagged proteins were detected with mouse anti-Flag (M2) or mouse anti-Epi monoclonal antibodies and lissamine rhodamine-conjugated goat anti-mouse IgG-IgM antibodies (Jackson ImmunoResearch Laboratories, Inc., West Grove, Pa.). Nuclei were stained with 4',6-diamidino-2-phenylindole (DAPI; Sigma, St. Louis, Mo.). Immunofluorescent images and DAPI staining were visualized on a confocal microscope as described previously (20).
Apoptosis assays and internucleosomal DNA fragmentation. SF-21 or TN-368 cells (0.8 × 106) were seeded in 60-mm-diameter culture dishes and transfected with 1 µg of the indicated plasmids. Cells were heat shocked 18 h after transfection and examined by light microscopy 12 or 24 h later. Phase-contrast photography of transfected cells was performed on an Olympus IX50 inverted microscope equipped with a PM-10AK camera. To determine the percentage of apoptosis (48), viable cells excluding trypan blue (10) were counted as described previously (44). For nucleosomal ladder preparation, cells were harvested at various times after heat shock, pelleted at 12,000 × g for 2 min, and resuspended in 20 mM Tris-HCl (pH 7.6)-10 mM EDTA-0.2% Triton X-100-200 µg of protease K per ml. After 12 to 18 h at room temperature, lysates were extracted four times with 1:1 (vol/vol) phenol-chloroform. DNA was precipitated with 2 volumes of ethanol and 0.1 volume of 5 M NaCl, treated with RNase A, and then subjected to electrophoresis through 1.2% agarose gels.
Cell division assays. hsOpIAPpacR cells (0.25 × 106) were seeded in 60-mm-diameter culture dishes and transfected with 0.5 µg of the appropriate plasmid. Cells were heat shocked 18 h after transfection and examined, as described above, over a 5-day period.
| |
RESULTS |
|---|
|
|
|---|
Association of human p53 and baculovirus p33 in insect cells. Baculoviruses are widely used as vectors for expression of biologically active proteins, and the AcMNPV recombinants expressing mammalian p53 proteins were previously constructed for this purpose. In the course of this work, we observed that a 33-kDa polypeptide (p33) consistently copurified with either murine or human p53. To identify p33, a human p53 was expressed in SF-21 cells by using vEVHp53wt (14) and purified by immunoaffinity procedures (56). Copurified p33 was separated from p53 by SDS-polyacrylamide gel electrophoresis and sequenced by Edman degradation. The sequence of the amino-terminal 17 residues was identical to that of the predicted product of the AcMNPV orf92 (Fig. 1). Alignment of AcMNPV p33 with its homologs in Bombyx mori nuclear polyhedrosis virus (BmNPV) and O. pseudotsugata nuclear polyhedrosis virus (OpMNPV) shows that the OpMNPV homolog contains a 24-amino-acid insertion near the C terminus of the protein but otherwise is well conserved, with approximately 81% sequence identity between the OpMNPV homolog and the AcMNPV or BmNPV homolog (Fig. 1). Computer-based analysis of the orf92-encoded protein sequences revealed no significant sequence homology to any other proteins in the available databases.
|
|
|
Subcellular localization of the p53 and p33 proteins in insect cells. The ability of FH-p33 or p33-F to bind EH-p53 suggested that these proteins should localize to the same subcellular location when coexpressed during infection or transfection. To determine their subcellular locations, infected SF-21 cells were transfected with plasmids expressing p33-F in the presence or absence of EH-p53. In the absence of EH-p53, p33-F displayed a diffuse staining pattern in the cytoplasm and a punctate staining pattern in the nucleus. In the presence of EH-p53, p33-F was localized exclusively to the nucleus and displayed a punctate staining pattern (Fig. 4). The same staining patterns were observed in uninfected cells and in AcMNPV-infected SF-21 cells transfected with plasmids expressing FH-p33 alone or with EH-p53 (data not shown). EH-p53 was localized to the nuclei of both infected (Fig. 4) and transfected (data not shown) cells in the presence or absence of p33, and it appeared to be distributed more uniformly than p33. Cells expressing EH-CAT or DAPI staining served as controls for cytoplasmic or nuclear localization. Thus, p53 appears to facilitate or direct p33 to the nucleus, where p33 targets a limited number of subnuclear sites, possibly in association with a portion of the nuclearly localized p53 protein.
|
p53 induces apoptosis in insect cells. An insect equivalent of p53 has not been identified, and it was of interest to determine if human p53 exerts any of its biological effects in the context of insect cells. To test if p53 induces apoptosis in insect cells, SF-21 and TN-368 cells were transfected with phsEHp53 or with pHSP70VI+EpihisCAT expressing EH-CAT as a control. Cells expressing EH-p53 exhibited extensive membrane blebbing and apoptotic body formation (Fig. 5A, top row), but cells expressing EH-CAT had no signs of apoptotic activity (Fig. 5A, bottom row). Nuclear condensation and fragmentation were confirmed by DAPI staining in cells exhibiting membrane blebbing (data not shown). Expression of EH-p53, but not EH-CAT, also resulted in cleavage of cellular DNA into oligonucleosomal fragments as early as 8 h after heat shock in SF-21 cells and by 24 h after heat shock in TN-368 cells (Fig. 5B). Therefore, p53 induces in insect cell lines SF-21 and TN-368 cell death with the morphological and biochemical features of apoptosis.
|
The baculovirus p35 and IAPs block p53-induced apoptosis. Baculoviral p35 and IAPs were coexpressed with EH-p53 to determine whether these proteins could block p53-induced apoptosis. Coexpression of p35, OpIAP, or CpIAP with EH-p53 resulted in a complete inhibition of p53-induced apoptosis (Fig. 6A). Both OpIAP and CpIAP completely restored viability of cells compared to the cells expressing CAT alone (Fig. 6B). AcIAP, also known as AcIAP1 (4, 11), was unable to block p53-induced apoptosis, consistent with previous observations that this baculoviral IAP is unable to block apoptosis in SF-21 cells (10). Cotransfection of phsEHp53 with a plasmid expressing p35 resulted in a threefold reduction in the percentage of apoptotic cells. However, the number of viable cells observed when p35 was cotransfected with CAT was less than that observed for the cells transfected with CAT alone, but no membrane blebbing was observed. This is consistent with previous observations that p35 may reduce cell growth in SF-21 cells (44). No protection was observed with a plasmid expressing AcIAP (Fig. 6). Thus, p35, OpIAP, and CpIAP, but not AcIAP, are able to block apoptosis initiated by p53 in transient expression assays.
|
p53 blocks cell growth in the presence or absence of p33 in insect cells. To determine if p53 is able to affect insect cell growth, we examined p53 expression in the SF-21-derived cell line hsOpIAPpacR, which stably expresses OpIAP and is partially resistant to apoptosis (38). hsOpIAPpacR cells were transfected with phsEHp53 or pHSP70VI+EpihisCAT, as a negative control, and heat shocked at 18 h after transfection. There was no evidence of unusual morphology, apoptosis, or necrotic cell death in these transfected cells (Fig. 7A and data not shown). Instead, there were twofold more viable EH-CAT-expressing cells than EH-p53-expressing cells at 50 h after heat shock and threefold more by 90 h (Fig. 7B). Thus, p53 blocks cell growth in insect cells in the presence of an antiapoptotic IAP. Expression of EH-p33 or p33-F alone in hsOpIAPpacR cells did not increase or reduce the rate of cell growth compared to the cells expressing the control EH-CAT (Fig. 7B). Coexpression of FH-p33 or p33-F with EH-p53 in this cell line had no influence on the ability of p53 to block cell growth.
|
Baculovirus p33 enhances p53-mediated apoptosis in insect cells. Since many other viruses encode p53 binding proteins which abrogate the function of p53, we determined if p33 could affect p53-mediated apoptosis. Cotransfection of SF-21 cells with plasmids coexpressing either FH-p33 or p33-F with EH-p53 increased the number of apoptotic cells twofold compared to the cells expressing EH-p53 only (Fig. 8A). Expression of FH-p33 or p33-F alone did not induce apoptosis in SF-21 cells, as determined both by the number of apoptotic cells and the absence of oligonucleosomal ladder formation (Fig. 8).
|
| |
DISCUSSION |
|---|
|
|
|---|
While using AcMNPV as a gene expression vector, we unexpectedly discovered that human p53 forms a complex with the product of viral orf92, p33. This previously uncharacterized protein is conserved among sequenced baculoviruses but has no obvious sequence relationship to other known proteins in the databases. Because p33 was the only protein found associated with purified p53 and the complex was stable through a variety of purification procedures (data not shown), we considered this interaction to be potentially informative regarding p33 function and have investigated it further. Interaction with human p53 directs p33 to distinct subnuclear locations, indicating that this interaction occurs in vivo as well as in vitro. Since there are no known invertebrate homologs of p53, the question of the biological relevance of this interaction remains unclear. However, human p53 exhibits biological activity in insect cells which is remarkably similar to its known activities in mammalian cells, and it thus seems likely that p53-associated pathways are conserved in insect cells.
We have found that human p53 induces apoptosis in SF-21 and TN-368 cells and that it can also block cell growth in SF-21 cells which express the antiapoptotic baculovirus gene Op-iap. Human p53 is considered to be the "guardian of the genome" in mammals, based on its ability to regulate cell cycle progression from G1 to S and its ability to induce apoptosis in response to DNA damage (reviewed in references 26 and 31). The ability of insect cells to respond to p53 in such a similar manner as mammalian cells indicates the conservation of the basic pathways and suggests that insect cells have a p53 homolog or a functional equivalent. Coexpression of p33 with p53 accentuates the ability of p53 to induce apoptosis which may reflect a functional as well as physical interaction of p33 and p53.
It is not clear what role, if any, p33 stimulation of p53-induced apoptosis might have in baculovirus infection. Like many large DNA-containing viruses, AcMNPV is known to induce apoptosis during infection of some host cells. In the case of SF-21 cells, the induction of apoptosis is correlated with the activation of caspases (6, 8), and the activation of SF-caspase-1 (1) is specifically implicated in this process (47). Whereas p35 blocks active SF-caspase-1, OpIAP prevents the activation of this caspase during virus infection (47). OpIAP, in turn, is known to bind and inhibit a number of insect apoptotic inducers, including Reaper, HID, GRIM, and Doom (20, 54, 55), which have no known homologs in vertebrates. Thus the involvement of a p53-like protein during baculovirus infection remains unclear, but the possibility that IAPs also interact with p53-like proteins is not precluded. There is evidence to suggest that viral DNA replication may be involved in triggering the induction of apoptosis (10, 34), and this might effectively mimic DNA damage or unscheduled cell cycle progression, which, in turn, might elicit a p53-like apoptotic response. The role of p33 in accentuating p53-mediated apoptosis would then be related to viral alteration of cellular factors in preparation for viral DNA replication, which might predispose the cell to p53-mediated apoptosis. Although overexpression of the AcMNPV ie-1 gene is sufficient to cause apoptosis in SF-21 cells (44), the dynamics of this induction suggest that other factors or events are also involved.
We have attempted to mutate orf92 by insertion of the lacZ gene into this locus, but all attempts to isolate stable double-crossover recombinants have been unsuccessful (data not shown), suggesting that orf92 is an essential baculovirus gene. It may be possible to further explore the function of p33 by finding an insect protein which interacts with p33 by using an interaction-based screening system. If such a protein exists, it would be interesting to determine if it has p53-like properties. Although p53 homologs have been identified in numerous vertebrates, none have yet been found in invertebrates.
| |
ACKNOWLEDGMENTS |
|---|
We thank Somasekar Seshagiri, Jeanne McLachlin, and especially Elena A. Prikhod'ko for valuable suggestions.
This research was supported in part by Public Health Service grants CA58316 (to C.P.) and AI23719 (to L.K.M.).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Department of Entomology, 413 Biological Sciences, University of Georgia, Athens, GA 30602. Phone: (706) 542-2294. Fax: (706) 542-2279. E-mail: miller{at}arches.uga.edu.
Present address: Molecular Viral Biology Section, Laboratory of
Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD 20892.
| |
REFERENCES |
|---|
|
|
|---|
| 1. |
Ahmad, M.,
S. M. Srinivasula,
L. Wang,
G. Litwack,
T. Fernandes-Alnemri, and E. S. Alnemri.
1997.
Spodoptera frugiperda caspase-1, a novel insect death protease that cleaves the nuclear immunophilin FKBP46, is the target of the baculovirus antiapoptotic protein p35.
J. Biol. Chem.
272:1421-1424 |
| 2. | Almog, N., and V. Rotter. 1997. Involvement of p53 in cell differentiation and development. Biochim. Biophys. Acta 1333:F1-F27[Medline]. |
| 3. | Avantaggiati, M. L., V. Ogryzko, K. Gardner, A. Giordano, A. S. Levine, and K. Kelly. 1997. Recruitment of p300/CBP in p53-dependent signal pathways. Cell 89:1175-1184[Medline]. |
| 4. | Ayres, M. D., S. C. Howard, J. Kuzio, M. L. Ferber, and R. D. Possee. 1994. The complete DNA sequence of Autographa californica nuclear polyhedrosis virus. Virology 202:586-605[Medline]. |
| 5. |
Bargonetti, J.,
I. Reynisdottir,
P. N. Friedman, and C. Prives.
1992.
Site-specific binding of wild-type p53 to cellular DNA is inhibited by SV40 T antigen and mutant p53.
Genes Dev.
6:1886-1898 |
| 6. | Bertin, J., S. M. Mendrysa, D. J. LaCount, S. Guar, J. F. Krebs, R. C. Armstrong, K. J. Tomaselli, and P. D. Friesen. 1996. Apoptotic suppression by baculovirus P35 involves cleavage by and inhibition of a virus-induced CED-3/ICE-like protease. J. Virol. 70:6251-6259[Abstract]. |
| 7. | Bottger, A., V. Bottger, A. Sparks, W. L. Liu, S. F. Howard, and D. P. Lane. 1997. Design of a synthetic Mdm2-binding mini protein that activates the p53 response in vivo. Curr. Biol. 7:860-869[Medline]. |
| 8. |
Bump, N. J.,
M. Hackett,
M. Hugunin,
S. Seshagiri,
K. Brady,
P. Chen,
C. Ferenz,
S. Franklin,
T. Ghayur,
P. Li,
P. Licari,
J. Markovich,
L. Shi,
A. Greenberg,
L. K. Miller, and W. W. Wong.
1995.
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35.
Science
269:1885-1888 |
| 9. |
Chen, C.-Y.,
J. D. Oliner,
Q. Zhan,
A. J. Fornace, Jr.,
B. Vogelstein, and M. B. Kastan.
1994.
Interactions between p53 and MDM2 in a mammalian cell cycle checkpoint pathway.
Proc. Natl. Acad. Sci. USA
91:2684-2688 |
| 10. |
Clem, R. J., and L. K. Miller.
1994.
Control of programmed cell death by the baculovirus genes p35 and iap.
Mol. Cell. Biol.
14:5212-5222 |
| 11. | Clem, R. J. 1997. Regulation of programmed cell death by baculoviruses, p. 237-261. In L. K. Miller (ed.), The baculoviruses. Plenum Press, New York, N.Y. |
| 12. | Dobner, T., N. Horikoshi, S. Rubenwolf, and T. Shenk. 1996. Blockage by adenovirus E4orf6 of transcriptional activation by the p53 tumor suppressor. Science 272:1470-1473[Abstract]. |
| 13. | Farmer, G., J. Bargonetti, H. Zhu, P. Friedman, R. Prywes, and C. Prives. 1992. Wild type p53 activates transcription in vitro. Nature 358:83-86[Medline]. |
| 14. |
Friedman, P. N.,
S. E. Kern,
B. Vogelstein, and C. Prives.
1990.
Wild-type, but not mutant, human p53 proteins inhibit the replication activities of simian virus 40 large tumor antigen.
Proc. Natl. Acad. Sci. USA
87:9275-9279 |
| 15. | Garkavtsev, I., I. A. Grigorian, V. S. Ossovskaya, M. V. Chernov, P. M. Chumakov, and A. V. Gudkov. 1998. The candidate tumor suppressor p33ING1 cooperates with p53 in cell growth control. Nature 391:295-298[Medline]. |
| 16. | Goga, A., X. Liu, T. M. Hambuch, K. Senechal, E. Major, A. J. Berk, O. N. Witte, and C. L. Sawyers. 1995. p53-dependent growth suppression by the c-Abl nuclear tyrosine kinase. Oncogene 11:791-799[Medline]. |
| 17. | Gottlieb, T. M., and M. Oren. 1996. p53 in growth control and neoplasia. Biochim. Biophys. Acta 1287:77-102[Medline]. |
| 18. |
Greenblatt, M. S.,
W. P. Bennett,
M. Hollstein, and C. C. Harris.
1994.
Mutations in the p53 tumor suppressor gene: clues to cancer etiology and molecular pathogenesis.
Cancer Res.
54:4855-4878 |
| 19. | Gu, W., X.-L. Shi, and R. G. Roeder. 1997. Synergistic activation of transcription by CBP and p53. Nature 387:819-823[Medline]. |
| 20. | Harvey, A. J., A. P. Bidwai, and L. K. Miller. 1997. Doom, a product of the Drosophila mod (mdg4) gene, induces apoptosis and binds to baculovirus inhibitor-of-apoptosis proteins. Mol. Cell. Biol. 17:2835-2843[Abstract]. |
| 21. | Haupt, Y., R. Maya, A. Kazaz, and M. Oren. 1997. Mdm2 promotes the rapid degradation of p53. Nature 387:296-299[Medline]. |
| 22. |
Hermeking, H.,
C. Lengauer,
K. Polyak,
T.-C. He,
L. Zhang,
S. Thiagalingam,
K. W. Kinzler, and B. Vogelstein.
1997.
14-3-3 is a p53-regulated inhibitor of G2/M progression.
Mol. Cell
1:3-11[Medline].
|
| 23. | Hink, W. F. 1970. Established insect cell line from the cabbage looper, Trichoplusia ni. Nature 226:466-467. |
| 24. |
Huibregtse, J. M.,
J. Scheffner, and P. M. Howley.
1993.
Cloning and expression of the cDNA for E6-AP, a protein that mediates the interaction of the human papillomavirus E6 oncoprotein with p53.
Mol. Cell. Biol.
13:775-784 |
| 25. | Kinzler, K. W., and B. Vogelstein. 1996. Life (and death) in a malignant tumor. Nature 379:19-20[Medline]. |
| 26. |
Ko, L. J., and C. Prives.
1996.
p53: puzzle and paradigm.
Genes Dev.
10:1054-1072 |
| 27. | Kubbutat, M. H., S. N. Jones, and K. H. Vousden. 1997. Regulation of p53 stability by Mdm2. Nature 387:299-303[Medline]. |
| 28. |
Kussie, P. H.,
S. Gorina,
V. Marechal,
B. Elebaas,
J. Moreau,
A. J. Levine, and N. P. Pavletich.
1996.
Structure of the MDM2 oncoprotein bound to the p53 tumor suppressor transactivation domain.
Science
274:948-953 |
| 29. | LaCount, D. J., and P. D. Friesen. 1997. Role of early and late replication events in induction of apoptosis by baculoviruses. J. Virol. 71:1530-1537[Abstract]. |
| 30. | Levine, A. J. 1993. The tumor suppressor genes. Annu. Rev. Biochem. 62:623-651[Medline]. |
| 31. | Levine, A. J. 1997. p53, the cellular gatekeeper for growth and division. Cell 88:323-331[Medline]. |
| 32. | Lill, N. L., S. R. Grossman, D. Ginsberg, J. DeCaprio, and D. M. Livingston. 1997. Binding and modulation of p53 by p300/CBP coactivators. Nature 387:823-827[Medline]. |
| 33. |
Lin, J.,
J. Chen,
B. Elenbaas, and A. J. Levine.
1994.
Several hydrophobic amino acids in the p53 amino-terminal domain are required for transcriptional activation, binding to mdm-2 and the adenovirus 5 E1B 55-kD protein.
Genes Dev.
8:1235-1246 |
| 34. | Lu, A., and L. K. Miller. 1995. The roles of eighteen baculovirus late expression factor genes in transcription and DNA replication. J. Virol. 69:975-982[Abstract]. |
| 35. |
Maheswaran, S.,
C. Englert,
P. Bennett,
G. Heinrich, and D. A. Haber.
1995.
The Wt1 gene product stabilizes p53 and inhibits p53-mediated apoptosis.
Genes Dev.
9:2143-2156 |
| 36. | Majima, K., S. Gomi, T. Ohkawa, S. G. Kamita, and S. Maeda. 1996. Complete nucleotide sequence of the 128,413 bp-long genome of the BmNPV: evolution and divergence of baculoviruses. GenBank accession no. L33180. |
| 37. | Manji, G. A., R. R. Hozak, D. J. LaCount, and P. D. Friesen. 1997. Baculovirus inhibitor of apoptosis functions at or upstream of the apoptotic suppressor P35 to prevent programmed cell death. J. Virol. 71:4509-4516[Abstract]. |
| 38. | McLachlin, J. R., and L. K. Miller. 1997. Stable transformation of insect cells to coexpress a rapidly selectable marker gene and inhibitor of apoptosis. In Vitro Cell. Dev. Biol. Anim. 33:575-579[Medline]. |
| 39. | Momand, J., G. P. Zambetti, D. C. Olson, D. George, and A. J. Levine. 1992. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 69:1237-1245[Medline]. |
| 40. | Oliner, J. D., J. A. Pietenpol, S. Thiagalingam, J. Gyuris, K. W. Kinzler, and B. Vogelstein. 1993. Oncoprotein MDM2 conceals the activation domain of tumour suppressor p53. Nature 362:857-860[Medline]. |
| 41. | O'Reilly, D. R., L. K. Miller, and V. A. Luckow. 1992. Baculovirus expression vectors: a laboratory Manual. W. H. Freeman and Company, New York, N.Y. |
| 42. | Picksley, S. M., B. Vojtesek, A. Sparks, and D. P. Lane. 1994. Immunochemical analysis of the interaction of p53 with MDM2; fine mapping of the MDM2 binding site on p53 using synthetic peptides. Oncogene 9:2523-2529[Medline]. |
| 43. | Polyak, K., Y. Xia, J. L. Zweier, K. W. Kinzler, and B. Vogelstein. 1997. A model for p53-induced apoptosis. Nature 389:300-305[Medline]. |
| 44. |
Prikhod'ko, E. A., and L. K. Miller.
1996.
Induction of apoptosis by baculovirus transactivator IE1.
J. Virol.
70:7116-7124 |
| 45. |
Prikhod'ko, E. A., and L. K. Miller.
1998.
Role of baculovirus IE2 and its RING finger in cell cycle arrest.
J. Virol.
72:684-692 |
| 46. | Russell, R. L. Q., and G. F. Rohrmann. 1993. A 25-kDa protein is associated with the envelopes of occluded baculovirus virions. Virology 195:532-540[Medline]. |
| 47. |
Seshagiri, S., and L. K. Miller.
1997.
Baculovirus inhibitors of apoptosis (IAPs) block activation of Sf-caspase-1.
Proc. Natl. Acad. Sci. USA
94:13606-13611 |
| 48. | Seshagiri, S., and L. K. Miller. 1997. Caenorhabditis elegans CED-4 stimulates CED-3 processing and CED-3 induced apoptosis. Curr. Biol. 7:455-460[Medline]. |
| 49. |
Szekely, L.,
G. Selivanova,
K. P. Magnusson,
G. Klein, and K. G. Wiman.
1993.
EBNA-5, an Epstein-Barr virus-encoded nuclear antigen, binds to the retinoblastoma and p53 proteins.
Proc. Natl. Acad. Sci. USA
90:5455-5459 |
| 50. | Teodoro, J. G., and P. E. Branton. 1997. Regulation of apoptosis by viral gene products. J. Virol. 71:1739-1746[Medline]. |
| 51. |
Thut, C. J.,
J. L. Chen,
R. Klemm, and R. Tjian.
1995.
P53 transcriptional activation mediated by coactivators TAFII40 and TAFII60.
Science
267:100-104 |
| 52. | Vaughn, J. L., R. H. Goodwin, G. J. Tompkins, and P. McCawley. 1977. The establishment of two cell lines from the insect Spodoptera frugiperda (Lepidoptera: Noctuidae). In Vitro 13:213-217[Medline]. |
| 53. | Vogelstein, B., and K. W. Kinzler. 1992. p53 function and dysfunction. Cell 70:523-526[Medline]. |
| 54. |
Vucic, D.,
W. J. Kaiser,
A. J. Harvey, and L. K. Miller.
1997.
Inhibition of reaper-induced apoptosis by interaction with inhibitor of apoptosis proteins (IAPs).
Proc. Natl. Acad. USA
94:10183-10188 |
| 55. |
Vucic, D.,
W. J. Kaiser, and L. K. Miller.
1998.
Inhibitor of apoptosis proteins physically interact with and block apoptosis induced by Drosophila proteins HID and GRIM.
Mol. Cell. Biol.
18:3300-3309 |
| 56. | Wang, E. H., P. N. Friedman, and C. Prives. 1989. The murine p53 protein blocks replication of SV40 DNA in vitro by inhibiting the initiation functions of SV40 large T antigen. Cell 57:379-392[Medline]. |
| 57. |
Wang, X. W.,
K. Forrester,
H. Yeh,
M. A. Feitelson,
J. R. Gu, and C. C. Harris.
1994.
Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3.
Proc. Natl. Acad. USA
91:2230-2234 |
| 58. |
White, E.
1996.
Life, death, and the pursuit of apoptosis.
Genes Dev.
10:1-15 |
| 59. |
Wu, X.,
J. H. Bayle,
D. Olson, and A. J. Levine.
1993.
The p53-mdm-2 autoregulatory feedback loop.
Genes Dev.
7:1126-1132 |
| 60. |
Yew, P. R.,
X. Liu, and A. J. Berk.
1994.
Adenovirus E1B oncoprotein tethers a transcriptional repression domain to p53.
Genes Dev.
8:190-202 |
| 61. |
Zhang, Q.,
D. Gutsch, and S. Kenney.
1994.
Functional and physical interaction between p53 and BZLF1: implications for Epstein-Barr virus latency.
Mol. Cell. Biol.
14:1929-1938 |
This article has been cited by other articles:
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| J. Bacteriol. | Mol. Cell. Biol. | Microbiol. Mol. Biol. Rev. |
|---|
| Clin. Vaccine Immunol. | ALL ASM JOURNALS |
|---|